BridgeMD
New treatment option for Coronary Artery Disease
Official title Intracoronary Optical Coherence Tomography Guidance Vs. Angiography Only Guidance for Treatment of Coronary In-stent Restenosis
ClinicalTrials.gov ID: NCT06779110
What this study is testing
- What it's testing
- Although advances in drug-eluting stents (DES) have substantially reduced the risk of coronary in-stent restenosis (ISR) and the need for target lesion revascularisation (TLR), ISR persists. There are several treatment options for ISR (conventional balloon angioplasty, cutting or scoring balloons, drug-coated balloons, repeat DES implantation or bypass surgery).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Informed consent signed
- Age ≥ 18 years
- Referred for angiography either in stable or ACS setting suitability for PCI through femoral or radial access
- A coronary in-stent restenosis between 70% and 99% in at least two projections in a vessel with a lumen diameter ≥ 2.25 - ≤ 5.75 mm (The severity of...
- Stable hemodynamics
You likely can't join if
- Inability to give informed consent
- Participation in another clinical study with an investigational product
- OCT pullback not technically feasible in vessel site
The study team makes the final eligibility decision.
Where it's taking place
- Aosta, Aosta, Italy
- Biella, Biella, Italy
- Cuneo, Cuneo, Italy
- Cona, Ferrara, Italy
- Genova, Genova, Italy
- Rivoli, Italy, Italy
- Trapani, Trapani, Italy
- Orbassano, Turin, Italy
- Turin, Turin, Italy
- Vercelli, Vercelli, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aosta, Aosta, Italy; Biella, Biella, Italy; Cuneo, Cuneo, Italy; Cona, Ferrara, Italy; Genova, Genova, Italy; Rivoli, Italy, Italy and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.